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Abstrak
Latar Belakang: Stimulasi respon sel T CD8+ spesifik Gag, terkait dengan penurunan viremia, kontrol replikasi virus, 
dan perkembangan penyakit yang lambat. Respon T CD8+ yang efektif juga dipengaruhi oleh sel T CD4+. Protein 
rekombinan Gag dapat diklona dan diekpresikan pada sistem prokariota, dan pada saat diimunisasi pada hewan 
coba atau manusia akan bersifat sebagai antigen eksogen. Antigen eksogen dapat menjadi antigen endogen dengan 
menambahkan protein yang mempunyai kemampuan bertranslokasi kedalam membran sel, salah satunya protein Vp22.
Metode: Transformasi Plasmid rekombinan didapatkan dari Pusat Penelitian dan Layanan Virologi 
Kanker Patobiologi Fakultas Kedokteran Universitas Indonesia-Rumah Sakit Pusat Nasional dr. Cipto 
Mangunkusumo (PPLVKP FK UI-RSCM), yang dilakukan transformasi pada sistem ekpresi prokariota 
dengan metode heat shock, yang dilanjutkan dengan ekpresi protein rekombinan. Purifikasi protein 
rekombinan dilakukan dengan kromatografi afinitas. Analisa berat molekul protein rekombinan dilakukan 
dengan SDS-PAGE. Western blotting dilakukan untuk mengaetahui reaktifitas protein rekombinan dengan 
antibodi poliklonal terhadap antigen p24. Transfeksi sel CHO dan imunisasi mencit DDY dengan protein 
rekombinan, untuk mengetahui kemampuan migrasi intraseluler serta stimulasi respon imun spesifik.
Hasil: Uji western blotting, menunjukkan protein rekombinan dapat berinteraksi dengan antibodi poliklonal 
terhadap antigen p24. Pengamatan mikroskop konfokal menunjukkan protein rekombinan berlokalisasi 
dengan endosom. Uji ELISA, menunjukkan respon IgG spesifik Gag setelah imunisasi pada mencit DDY.
Kesimpulan: Protein rekombinan dapat diekspresikan pada sistem ekspresi prokariota. Kemampuan 
migrasi intrasseluler protein rekombinan pada sel CHO belum dapat dibuktikan. Protein rekombinan dapat 
menstimulasi respon IgG spesifik Gag. (Health Science Journal of Indonesia 2017;8(2):59-67)
Kata Kunci:  Protein rekombinan Gag dan Vp22-Gag; Migrasi intraseluler, Respon IgG spesifik Gag.
Abstract
Background: Stimulation of Gag-specific CD8+ T-cell response, associated with reduction in viremia, viral replication 
control, and slow disease progression. Effective CD8+ T cell response is also influenced by CD4+ T cells. Gag recombinant 
protein may be cloned and expressed in the prokaryotic system and when they are immunized in experimental animals 
or human will have property as exogenous antigens. Exogenous antigens may become endogenous antigens by adding 
proteins that have the ability to translocate into the cell membrane, one of which is the Vp22 protein.
Methods: Recombinant plasmids were obtained from Research and Services Centers of Virology and 
Cancer Patobiology Medical Faculity Universitas Indonesia-dr. Cipto Mangunkusumo National Central 
General Hospital (PPLVKP FK UI-RSCM) which transformation to prokaryotic expression system with heat 
shock method was followed by expression of recombinant proteins. Purification of recombinant proteins 
was performed with affinity chromatography. The molecular weight analysis of recombinant proteins was 
performed with SDS-PAGE. Western blotting was performed to determine the reactivity of recombinant 
proteins with polyclonal antibodies against p24 antigens. Transfection of Chinese Hamster Ovary (CHO) 
cell and immunization of Deutschland, Denken, and Yoken (DDY) mice with recombinant proteins was 
conducted to determine intracellular migration ability and stimulation of specific immune response.
Results: Western blotting test, indicating recombinant protein may interact with polyclonal antibody against p24 antigens. 
The observation of a confocal microscope showed recombinant proteins localized with endosomes. The Enzyme-linked 
Immunosorbent Assay (ELISA) test indicates Gag-specific IgG response after immunization in DDY mice.
Conclusion: Recombinant proteins may be expressed on a prokaryotic expression system. The ability of 
recombinant protein intracellular migration in CHO cell has not been proven. Recombinant proteins may 
stimulate Gag-specific IgG response. (Health Science Journal of Indonesia 2017;8(2):59-67)
Keywords: Gag and Vp22-Gag recombinant proteins; intracellular migration, Gag-specific IgG response.
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HIV is a virus of the Retroviridae family, Ortho-
retrovirinae subfamily, the lentiviruses genus (which 
comes from the Latin, lentus, meaning slow),1 which 
is the main cause of AIDS, ie: a state of decreasing 
immune function, which thus increases the vulnerability 
to a number of infections with fatal consequences, 
called opportunistic infections.2,3 In 2014, there were 35 
million people with HIV and 25,000,000 people with 
HIV-related deaths worldwide, 90% cases of which 
occur in developing countries, which treatments for 
the infection generally were not available.4 Indonesia 
reported 150,296 HIV cases and 9,796 HIV-related 
deaths in 2014.5 
HIV infection control was done with ARV treatment. 
ARV administration may reduce the number of virus 
in circulation to a level that may not be detected by 
the existing examination system,6 but ARV may not 
eliminate the virus. Prolonged ARV administration 
may cause side effects, including: toxicity and 
resistance.7-9 Thus, the infection development should 
be controlled, by developing vaccine candidates.10 
One way to produce vaccine candidates that have a 
good effectiveness is by developing vaccine candidate 
based on viral subtypes which are predominant in 
the population.3,4,11,12 The dominant HIV subtype in 
Indonesia is CRF01_AE.13 
Gag protein, is a virion-building structural protein, which 
is relatively more sustainable than other viral proteins, 
and may stimulate the immune response, so it can be 
developed as a vaccine candidate.14,15 Gag recombinant 
protein subunit vaccine candidates may be cloned and 
expressed in prokaryotes system. The vaccine when 
injected to the experimental animal or human will have 
property as an exogenous antigens.16, 17
In developing a vaccine, an adjuvant which is 
molecule that may increase the vaccine potential, 
is generally added.18 Vp22 protein has been used as 
DNA vaccine adjuvant, due to its ability to induce the 
proteins spread intercellularly. Some studies indicated 
that DNA vaccine whose antigens is expressed in a 
fusion manner with Vp22 will improve the antibodies 
response.19 Vp22 protein is a HSV-1 tegumen protein 
encoded as gene ul49,20, 21 which have translocation 
capability into cell.22, 23 The intracellular migration 
ability of Vp22 protein has been demonstrated 
in several researches, including among others: 
transfection in COS-1 cell,24 transfection in BT549 
cell,25 and transfection in MCF-7 cell.23 
The stimulation of Gag-specific CD8+ T cell response 
is associated with reduction in viremia, viral 
replication control and slow disease progression.14 
The effective CD8+ T response was also influenced 
by the CD4+ T cells.26,27 This study is aimed at 
obtaining Vp22-Gag recombinant protein HIV-1 
subtype CRF01_AE, and knowing the intracellular 
migration ability of recombinant protein as well as 
specific immune response stimulation of recombinant 
protein.
METHOD
Recombinant plasmids
pQE-80l plasmid (Invitrogen, Carlsband, CA) 
which have been inserted with gag and vp22-gag 
genes were obtained from PPLVKP FK UI-RSCM. 
Recombinant plasmid is confirmed by sequencing.
E.colli BL-21CP
E. colli BL-21CP (DE3)-RIPL, with genotype BF- 
opmT hsdS (rB- mB-) dcm+ Tett gal ƛ (DE3) ENDA 
The [argU proL CamT] [argU ileY leuW Strep/
SpecT] (Aglient, Santa Clara, CA). The bacteria were 
cultured in liquid LB medium, with the addition 
of 0.1 M MgCl2 as much as 
1/5 culture volume, 
incubated in ice for 15 minutes and then centrifuged 
3.500 g, 4°C, for 10 minutes. The supernatant was 
removed and added with 100 mM CaCl2 as much as 
1/100 culture volume. Competent bacteria may be used 
as a recombinant protein expression system.28 
Chinese Hamster Ovary (CHO) cell 
CHO cell were obtained from the American Type 
Culture Collection (Manassas, VA). CHO cell were 
cultured in DMEM medium, which was added 
with 15% fetal bovine sera, 2 mmol/l L-glutamine, 
2 mmol/l HEPES, 100 pmol/l non-essential amino 
acids, 10 mg/l phenol red, and 1,000 mmol/l 
peniciline-streptomycine.28
Deutschland, Denken, and Yoken (DDY) mice
Male DDY mice at 5 weeks of age which were 
bred inbreeding manner were obtained from PT. 
Biofarma-Bandung. They were kept for 2 weeks in 
the laboratory before the treatment was administered.
Transformation of recombinant plasmids
The transformation was conducted with heat shock 
method, with composition of 50 µl and 5 µl plasmid 
(concentration of 100 ng) were added. 200 µl SOC 
medium were added and incubated at 37o C, for 60 
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minutes, at 150 rpm. A total of 50 µl suspension 
was cultured at LB agar (added with antibiotic 
ampicillin, at a concentration of 1.000 µg, as much 
as 1/1,000 volumes of suspension) and incubated at 37° 
C for 18 hours.28 
Expression of recombinant proteins
Expression of recombinant proteins was made by 
culturing the bacteria which had been transformed 
with the recombinant plasmid in 100 ml TB broth 
(added with antibiotic ampicillin at concentration of 
1,000 µg, as much as 1/1,000 suspension volume) and 
incubated for 6 hours, at 37° C, 150 rpm. In the 2nd 
hour, 100 mM IPTG was added (as much as 1/1,000 
volume of bacterial suspension).28
One ml bacterial culture was taken in the 2nd hour 
before IPTG was added and every hour after was 
IPTG added. It was centrifuged for 1 minute, at 4o C, 
12,000 rpm and the supernatant was discarded. The 
pellets obtained were stored at 4° C for SDS-PAGE 
analysis.28
Purification of recombinant proteins
The recombinant protein was purified with native 
methods, in accordance with the procedures of 
The QIA Expressionist: A handbook for high-level 
expression and purification of 6xHis-tagged proteins 
5th ed.29
Western bloting of recombinant proteins
Blotting was done with semidry method, which was 
constant 25 volts, for 30 minutes. Ponceau was added 
to nitrocellulose membrane to look at the blotting 
efficiency.28 The first antibodies used were: (1) HIV-
infected patient sera; (2) HIV-un infacted patient 
sera; (3) rabbit antibodies against p24 antigens; (4) 
and rabbit antibodies against E.colli. The second 
antibodies were: (1) antibody against biotin-labelled 
human antibodies; (2) and antibody against biotin-
labelled rabbit antibodies.28 A 70 µl subrat (imun-star 
reagent [Biorad] with reagent ratio A: B = 1: 1) was 
added. It was incubated in the dark for 1 minute and 
observed at Quant LS4000.28 
Transfection of CHO cell
300 µl CHO cell at concentration of 5x105 cell/ml 
were added with 1 ml complete DMEM medium that 
had been added with dextran tetramethylrhodamine. 
It was incubated at 37o C, 5% CO2, for 48 hours. 
CHO cell were added with recombinant proteins 
and immunostaining was then performed. The CHO 
cell that were added with eGFP and gag plasmids 
were incubated at 37o C, 5% CO2, for 48 hours and 
immunostaining was then performed.28 
Immunostaining of CHO cell
CHO cell were washed with PBS 1x, and fixated with 
3,7% formaldehyde in PBS 1x. It was permeabilized 
with 0,2% triton x-100 in PBS 1x. The 1st antibodies, 
namely: rabbit antibodies against p24 antigens, at 
concentration of 1/10,000 in 2% BSA, and washed with 
PBS 1x. The 2nd antibodies, namely: antibody against 
FITC-labeled rabbit antibodies, at concentration of 1/10.000 
in 2% BSA, washed with PBS 1x. The cover slide was 
moved to a glass object with mouwil. The observation 
was performed with a confocal microscope.28
Mice immunized
The total DDY mice were calculated with Federer 
colculation, namely: (t-1) (n-1)> 15.30 Mice blood 
was collected from the submandibular vein one week 
before the first immunization. Immunization was done 
three times with interval of each immunization of 
two weeks. Immunization was done intramuscularly 
on quadriceps muscle.28 Each mice was given with 
100 µg antigens at 5 µg concentration in each 
immunization and 10 µl DMRIE-C was added.31-33
Enzyme-linked Immunosorbent Assay (ELISA)
ELISA was performed on plate 96 well which was 
added with 70 µl Gag recombinant protein with 
concentration 12,5 µg/ml in carbonate/bicarbonate 
pH 9,6 and incubated for 60 minutes, at 37o C. It was 
washed with 100 µl 0,05% tween-20 in PBS 1x. 80 µl 
5% skim milk was added in PBS 1x and incubated for 
60 minutes, at 370 C. It was washed with 100 µl 0,05% 
tween-20 in PBS 1x. 50 µl mice sera was added (each 
sera was diluted with 1/27, 
1/81, 
1/243, and 
1/729 in 0,1% 
skim milk). It was incubated for 60 minutes, at 37o C 
and was washed with 100 µl 0,05% tween-20 in PBS 
1x. 50 µl antibody against biotin-labeled mice sera 
were added at concentration of 1/5.000 in 0,1% skim 
milk and incubated for 60 minutes, at 37o C. It was 
washed with 100 µl 0,05% tween-20 in PBS 1x and 
added with 50 µl streptavidin-HRP at concentration 
of 1/10.000 in 0,1% skim milk and incubated for 60 
minutes, at 37o C and washed with 100 µl tween-20 
0,5% in 1x PBS. 48 µl OPD substrates were added 
and incubated for 10 minutes at room temperature 
and added with 24 µl 2,5M H2SO4 in PBS 1x. Then 
read with spectrophotometer λ = 450nm.28 
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Statistical analysis
Statistical analysis was performed using SPSS 
software (v 20.0). Mice antibody titers data before 
and after immunization were tested with paired t-test 
if the data were normally distributed, if not normally 
distributed then the data were tested with Wilcoxon 
test. Mice antibody titers data after immunization 
in each treatment group were tested with one-way 
anova test followed with LSD test, if the data were 
not normally distributed and not homogeneous, then 
Kruskal-Wallis test was performed, followed with 
Mann-Whitney test. The value of p < α, showed data 
was significantly different. The value of α used is 
0,05 with 95% confidence level.34, 35
RESULTS
Transformation of recombinant plasmids
E.colli BL-21CP which had been transformed with 
the recombinant plasmids might grow in LB agar 
that contained the antibiotic ampicillin. Meanwhile, 
the bacteria control, namely: E.colli BL-21CP which 
was not transformed with the recombinant plasmids 
could not grow on the LB agar that contained the 
antibiotic ampicillin (Data not showed).
Expression of recombinant proteins
SDS-PAGE of Gag protein-expression bacteria there 
were dominant bands located between the protein 
ladder with the molecular weight of 30 KDa and 40 
KDa. On the other hands, the Vp22-Gag protein-
expression bacteria had dominant bands located 
between the protein ladder with the molecular 
weight of 40 KDa and 50 KDa. At the 1st hour after 
induction, the protein band continued to thicken 
when the incubation period increased (Data not 
showed).
Purification of recombinant proteins
SDS-PAGE analysis of recombinant proteins after 
purification showed that in the flowthrough there were 
some bands, in the wash buffer there was band, and 
in the elution there was one band. In the 1st elution, 
the band was the thickest and in the further elution 
the band was getting thinner. The Gag recombinant 
protein bands migrated between protein ladder with 
molecular weight of 30 KDa and 40 KD (Figure 1). 
Meanwhile, the Vp22-Gag recombinant protein band 
migrated between the protein ladder with molecular 
weight of 40 KDa and 50 KDa (Figure 2).
Concentration of recombinant proteins
The concentration of recombinant proteins that had 
been was measured with Bradford method. The 
results of the measurement were as follows: Gag 
recombinant protein was 0,080 mg/ml and Vp22-
Gag recombinant protein was 0,1318 mg/ml. The 
recombinant protein was added with 10% glycerol 
(of the total volume) and stored in a freezer at -20oC, 
to be used in transfection of CHO cells and DDY 
mice immunization.
Western bloting of recombinant proteins
Western blotting showed that the rabbit antibodies 
against p24 antigens and the HIV-infected patients 
Figure 1. SDS-Page of recombinant protein Gag after 
purification. Line 1:  protein ladder (Page ruler BR 
unstained), line 2: flowthrough, line 3: wash 1, line 4: 
wash 2, line 5: wash 3, line 6: wash 4, line 7: wash 5, 
line 8: elution 1, line 9: elution 2, and line 10: elution 
3. Polyacrylamide gel 12%, electrophoresis 60 minute 
and 150 V. The arrows showed band of recombinant 
protein that migrated between the protein ladder with a 
molecular weight of 30 KDa and 40 KDa.Primary data
Figure 2. SDS-Page of recombinant protein Vp22-Gag after 
purification. Line 1:  protein ladder (Page ruler BR 
unstained), line 2: flowthrough, line 3: wash 1, line 
4: wash 2, line 5: wash 3, line 6: wash 4, line 7: 
wash 5, line 8: elution 1, line 9: elution 2, and line 
10: elution 3. Polyacrylamide gel 12%, electro-
phoresis 60 minute and 150 V. The arrows showed 
band of recombinant protein that migrated between 
the protein ladder with a molecular weight of 40 
KDa and 50 KDa.Primary data
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sera interact with Gag and Vp22-Gag recombinant 
protein, which was indicated by the presence of 
bands between protein ladder with molecular 
weight of 30 KDa and 50 KDa. In the recombinant 
proteins added with antibodies againsts E.colli 
antigens and sera of HIV-uninfected patients sera, 
there were several protein band patterns, but the 
protein band patterns formed were different from 
the band pattern of the recombinant proteins that 
were added with antibodies against p24 antigens 
(Figure 3).
 
Transfection of CHO cell
Confocal microscopic showed that Gag and Vp22-
Gag recombinant proteins which were formulated 
with DMRIE-C, were localized with endosomes 
as indicated by yellow fluorescence, which were 
a combination of green (antibodies against FITC-
labeled p24 antigens) and red (endosome organelles 
dye, namely: dextran tetramethylrhodamine) 
(Figure 4).31 
Mice immunized
The results of antibodies titers were significantly 
different between baseline and termination, as 
expressed with p < 0,05, when it is done with paired 
t test (Figure 5). While Mann-Whitney test showed 
a comparison of termination sera between treatment 
groups, showing that the group two had the highest and 
most significant antibodies titers than other treatment 
groups, as expressed with p <0,05(Figure 6).
DISCUSSION
Expression of recombinant proteins in prokaryotic 
expression system
Plasmids encoded Gag and Vp22-Gag recombinant 
proteins that used in this study was the DNA resulted from 
RNA reverse transcription of virus that did not undergo 
the codon optimization for the mammalian expression 
system. The differences in viral organisms as DNA to 
be expressed and prokaryotes that acted as vectors of 
protein expression may become obstacles in the process 
of protein translation. This is due to differences in 
codons between the two organisms. In this study, E.colli 
BL-21CP was used to express the Gag dan Vp22-Gag 
recombinant proteins with the aim of overcoming the 
problems of codon differences between the organisms.
Figure 3. Western blotting of recombinant protein. 
Line 1: protein ladder (Page ruler BR unstained), 
line 2: recombinant protein Gag added with anti-
body that reacted to p24 antigens, line 3: recom-
binant protein Vp22-Gag added with antibody 
that reacted to p24 antigens, line 4: recombinant 
protein Gag added with antibody that reacted 
to E.colli antigens, line 5: recombinant protein 
Vp22-Gag added with antibody that reacted to 
E.colli antigens, line 6: recombinant protein Gag 
added with HIV-infacted patiens sera, line 7: re-
combinant protein Vp22-Gag added with HIV-
infacted patiens sera, line 8: recombinant protein 
Gag added with HIV-uninfacted patiens sera, line 
9: recombinant protein Vp22-Gag added with 
HIV-uninfacted patiens sera, and line 10: protein 
ladder (Precesion plus protein TM all blue stan-
dart). The arrows showed band of recombinant 
protein that laid between the protein ladder with a 
molecular weight of 30 KDa and 50 KDa. Primary data
Figure 4. Observation of CHO cell transfected recom-
binant proteins with confocal microscope. 
Immunostained of CHO cell performed with 
dextran tetramethylrhodamine that can be col-
ored endosome (red). Recombinant proteins 
that laid within cytosol will have green fluores-
cence (fitc fluorescence). On the other hand, re-
combinant proteins that laid within endosome 
will have yellow fluorescence (combination of 
red and yellow).Primary data
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The recombinant protein expression utilized the 
IPTG inducer, which is thio-galactosidase. IPTG 
will bind with Lacl and activates the operon lac. The 
operon lac will increase the expression of T7 RNA 
polymerase, and may bind with the T5 promoter 
contained in the recombinant plasmids.36-38 The low of 
IPTG concentration, ie: 1,5 to 2,5 µM/cell may alter 
expression of operon lac activities. At high of IPTG 
concentrations, transasetylase will be performed by 
LacA in the cell, which converts IPTG into isopropyl 
6-o acetyl-pD thiogalaktopironiside and exerted from 
the cell and has no properties as an inducer.37 IPTG 
concentrations used in this study was 0,1 mM/ml.
The expression level of recombinant proteins was also 
influenced by the incubation temperature, time after 
induction, and volume of media culture. The volume 
of culture medium used is determined by the level 
and location of protein expression. The advantages 
of IPTG as an inducer, among others are as follows: 
it may produce high bacteria density, relatively simple 
use, and does not require a bacterial growth monitoring, 
as well as a relatively short induction time (where the 
incubation time of 36 hours means the highest protein 
expression, while > 36 hours means protein declining). 
The decreasing concentration of IPTG may reduce 
cell density (decrease of 0,01 mM IPTG may decrease 
expression level of 10 to 15 times).39, 40 
The recombinant proteins were denaturated, when 
analyzed with SDS-PAGE. SDS is a anionic detergent 
contained in the SDS-PAGE sample buffer, and 
instrumental in cutting the hydrophobic protein 
bonds. Denaturation process is also done by heating 
(> 60o C), and addition of other reducing agents (eg: 
in-thiothreitol or DTT and 2- β mercapethanol), 
which reduces the disulfide bonds. Denaturation of 
recombinant proteins will eliminate the protein’s 
tertiary (even quaternary) structure, so the proteins are 
in the primary or linear structure.41,42 The weaknesses 
in determination of proteins molecular weight, using 
SDS-PAGE include error rate of 20%.43,44
The Gag and Vp22-Gag recombinant proteins are 
expressed in fusion state with 6xHistaq. The 6xHistaq 
fused with a recombinant protein has a small 
molecular weight, and not charged at physiological 
pH, so that it did not affect the protein structure 
expressed in fusion manner both on the end of amino 
and carboxyl. Additionally, the 6xHistaq is not 
immunogenic,40,45 and so will not induce an immune 
response that may affect the vaccine effectiveness
The Gag and Vp22-Gag recombinant proteins were 
successfully purified using Ni-NTA in the native 
Figure 5. Comparison of antibody titers between 
termination and baseline mice sera. Group 
1: immunized with recombinant protein Gag 
formulated DMRIE-C, group 2: immunized 
with recombinant protein Vp22-Gag formulated 
DMRIE-C, and group 3: immunized with PBS 
1x. Symbol (*) showed that p value < 0,05. 
Analysis data with paired t-test. Antibodies 
titers based on ratio to highest poll sera.Primary data 
Figure 6. Comparison of antibody titers of termination 
sera between mice group. Antibodies titers of 
termination corrected with each antibodies titers 
of baseline. Group 1: immunized with recombi-
nant protein Gag formulated DMRIE-C, group 
2: immunized with recombinant protein Vp22-
Gag formulated DMRIE-C, and group 3: immu-
nized with PBS 1x. Symbol (*) showed that p 
value < 0,05. Analysis data with Mann-Whitnet 
test. Antibodies titers based on ratio to highest 
poll sera.Primary data
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state. The protein was purified from supernatant of 
bacterial sonication results. The successful protein 
purification in the native state indicated a big chance 
that the protein when expressed in bacteria was not 
in the inclusion bodies.40 In addition, that the protein 
may be purified in a native state showed that the 
6xHistaq could be accessed by Ni-NTA and not 
covered by the protein’s tertiary structure.
The concentration of purified protein with Ni-NTA 
was measured with Bradford method. The protein 
concentrations were calculated based on the linear 
equations of BSA standard curve that were made based 
on the ratio of OD with known BSA concentrations. 
The results of measurement of concentration of Gag 
and Vp22-Gag recombinant proteins are as follows: 
0,080 mg/ml and 0,1318 mg/ml. Ni-NTA resins were 
capable of binding 5 to 10 mg 6xHis Tag proteins/ml 
(eg 1 ml agarose Ni-NTA was capable of binding 300 
to 400 nmol proteins).29,40,45
The recombinant proteins that had been purified 
still contained proteins contamination from E. colli. 
This is because E.colli proteins may bind with Ni-
NTA resin through hydrophobic interactions. The 
contamination of E. colli proteins may be overcome 
with addition of detergent (eg Triton X-100 or Twen-
20 with a concentration of less than 1%), with addition 
of adding NaCl salt solution with a concentration of 
less than 500 mM NaCl, and addition of glycerol or 
ethanol with a concentration of <2 0%.40, 45
Western blotting indicated that Gag and Vp22-Gag 
recombinant proteins may interact with antibodies 
against p24 antigens from HIV-1 subtype CRF01_
AE and HIV-infected patiens sera. This implied 
that Gag and Vp22-Gag recombinant proteins were 
confirmed as HIV proteins and most likely they may 
stimulate the immune response. 
Interaceluller of recombinant proteins on CHO cell
Localization of recombinant proteins with endosomes 
suggested that recombinant proteins translated into 
the cell in endocytosis manner, and likely would 
be destroyed in the lysosome. This is consistent 
with the results of analysis of the Gag-specific IgG 
response in mice immunized with Gag and Vp22-
Gag recombinant proteins, indicating an increase in 
antibodies titers. The formation of antibodies in the 
body is affected by the type of antigens presented by 
the antigens presenting cell (APC). The exogenous 
antigens originating from outside the cell will be 
presented to CD4+ T cells through the class I MHC 
molecules after passing through the endocytosis and 
proteolysis process in lysosomes. Meanwhile, the 
endogenous antigens produced by the cell itself will 
be presented to CD8+ cells through the class I MHC 
molecule, without prior processing in the lysosome.
In this study the ability of Gag and Vp22-Gag 
recombinant proteins to translocate into the intracellular 
environment were not proven yet, because in this study, 
the process of delivery of both proteins was done with 
the help of a delivery system such as DMRIE-C.
Reactivity of DDY mice sera after immunized
Reactivity of sera against Gag recombinant protein 
indicated an increase antibody titers before and after 
immunization with some antigens formulations. It 
showed that the antigens formulation of recombinant 
proteins used for immunization of DDY mice might 
activate CD4+ T cell that contribute to the process 
of antibody class switching on B cells. CD4+ T 
cell activation occurred as a result of activation by 
exogenous antigens. This indicated that the addition 
of Vp22 to the construction of the recombinant 
protein and formulation with DMRIE-C did not affect 
the ability of exogenous antigens to remain being 
processed via endocytosis and proteolysis in the 
lysosome. The vaccine formulation with DMRIE-C 
was expected to help the antigens incoming through 
endocytosis pathway to perform endosomal 
escape mechanism so it may be ‘transformed’ into 
endogenous antigens that activated the CD8+ T cell.
Formulation of Gag recombinant protein and 
formulation with DMRIE-C, it was indicated that 
the antibodies titers was the highest compared with 
the Vp22-Gag recombinant protein and formulation 
with DMRIE-C. This lower antibodies titers when 
compared with the group of mice likely was due to a 
number of Gag recombinant protein that slip out of 
the endosome and existed in the cytosol. 
The Vp22 addition to the construction of Vp22-Gag 
recombinant protein was shown to improve the ability 
of the recombinant protein to translocate across the cells, 
through the cell junction.22 The Vp22 ability to translocate 
to the cell around it will increase the cell which expresses 
the Vp22-Gag recombinant protein as an endogenous 
antigens. The Vp22-Gag recombinant protein both 
formulated with DMRIE-C may induce the formation 
of Gag-specific IgG response and activate CD4+ T cell, 
although the resulting antibodies titers is not as high as 
the antigens formulation of Gag recombinant protein 
with DMRIE-C. The utilization of Vp22 as adjuvant 
of sub unit protein vaccine with the aim of improving 
the response of antibodies formation has not been 
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reported. The results of the study also showed that 
the addition of Vp22, although it did not improve the 
antibody formation response, proved that the Vp22 
did not inhibit the activation of CD4+ T cells and the 
formation of antibody responses. 
The study by Saha (2006), proved that the complete 
sequence of Vp22 protein had the ability to stimulate the 
antibodies response when fused with the nucleoprotein. 
However, Vp22 protein might not stimulate antibodies 
response when expressed incompletely, ie: Vp221-267.
19 
The study by Nishikawa (2010) proved that Vp22 
protein with incomplete sequences, ie: Vp22268-301, 
had transmembrane migration capabilities, and could 
increase the cytosol delivery from of fused molecules. 
The cytosol delivery was important process in 
stimulating the peptide-mediated CTL response.22
The highest antibodies response was generated by 
a group of mice immunized with Gag recombinant 
protein formulation with DMRIE-C. This suggested 
that the addition of Vp22 were not able to improve 
the antibodies response, but were able still to induce 
the activation of CD4+ T cell. This is in line with 
the purpose of utilization of ALMR delivery systems 
and the addition of Vp22 adjuvants successively to 
increase protein insertion from the endosome and 
increase the intracellular migration.
In conclusion, in this study, the Gag and Vp22-Gag 
recombinant proteins were able to be expressed in 
prokaryotic expression system.  The ability of the Vp22-
Gag recombinant protein translocation in mammalian cell 
had not been proven. The Vp22-Gag recombinant protein 
was able to stimulate the Gag-specific IgG response.
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